CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Grindeks AS Company Snapshot
Grindeks AS operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other pharmaceutical manufacturers in Europe: Dottikon ES Holding AG of SWITZERLAND (2019 sales of 147.71 million Swiss Francs [US$161.08 million] of which 100% was The pharmaceutical), Alliance Pharma Plc of UNITED KINGDOM (£135.64 million [US$177.07 million] of which 100% was Pharmaceuticals), and Olainfarm AS (137.22 million Euros [US$161.06 million] of which 63% was Medicine Production).

Sales Analysis. During the year ended December of 2019, sales at Grindeks AS were 141.42 million Euros (US$165.98 million). This is a decrease of 2.8% versus 2018, when the company's sales were 145.48 million Euros . Contributing to the drop in overall sales was the 3.7% decline in Final Dosage Forms, from 138.03 million Euros to 132.86 million Euros . . However, these declines were partially offset by the increase in sales of Active Pharmaceutical Ingredients (up 14.9% to 8.56 million Euros ) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Grindeks AS
  Stock Performance Chart for Grindeks AS
 
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 15.40
(Figures in Euros )
1 Week 2.0%   13 Weeks 9.2%  
4 Weeks 9.6%   52 Weeks 30.5%  
 
Grindeks AS Key Data:
  Ticker: GRD1R Country: Latvia
  Exchanges: RGA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 141,417,586
(Year Ending Jan 2020).
Employees: 1,505
  Currency: Euros Market Cap: 147,609,000
  Fiscal Yr Ends: December Shares Outstanding: 9,585,000
  Share Type: Closely Held Shares: 8,896,147
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.